Legal Representation
Attorney
Michael T. Smith
USPTO Deadlines
Next Deadline
1395 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-23)
Due Date
May 23, 2029
Grace Period Ends
November 23, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 23, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 23, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 18, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 17, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Mar 25, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 25, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 13, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 13, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 13, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 19, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 19, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 29, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 17, 2022 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| May 3, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 3, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 3, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 3, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 3, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 2, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 2, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 2, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 9, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 9, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 9, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 21, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 21, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 21, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 2, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 2, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 2, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 2, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Aug 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 2, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 19, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 4, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 4, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 4, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 4, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| May 4, 2021 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| May 4, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 4, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 15, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Custom manufacture of pharmaceuticals, biopharmaceuticals, nutraceuticals, vitamins by pharmaceutical compounders
First Use Anywhere:
20201000
First Use in Commerce:
20201000
Class 042
Product development for others; Pharmaceutical drug development services; Scientific research and development; pharmaceutical research services; Research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Research in the field of biomedical science; Pharmaceutical preparations and medicines development; Research and development services in the field of antibodies
First Use Anywhere:
20201000
First Use in Commerce:
20201000
Classification
International Classes
040
042